03:52 PM EST - Isotechnika Pharma Inc. : announced positive anti-hepatitis C virus results from the second round of in vitro testing of its cyclophilin antagonist molecules. Contractors funded by the National Institute of Allergy and Infectious Diseases, part of the U.S. National Institutes of Health, carried out the testing. Isotechnika Pharma Inc.
shares T.ISA are trading unchanged at $0.07.
